Investigation Of A New Medication (GW642444) In Asthmatic Patients

NCT00354874 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GW642444
DRUG: Placebo
DRUG: salmeterol 50mcg

Sponsor

GlaxoSmithKline